ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.9776
+0.1906 (24.22%)
At close: Jun 6, 2025, 4:00 PM
0.9448
-0.0328 (-3.36%)
After-hours: Jun 6, 2025, 7:55 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $286.15 million as of June 6, 2025. Its market cap has increased by 20.98% in one year.
Market Cap
286.15M
Enterprise Value
-38.98M
1-Year Change
20.98%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $286.15M, an increase of 466.07%. That is a compound annual growth rate of 55.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 126.63M | -41.45% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |